AzTrials
AzTrials

Access to Primary CareENGAGENCT07439627

Evaluating Novel Approaches That Engage and Support Vulnerable Patient Groups to Equitably Access Primary Care

A study testing Primary care connector in people with Access to Primary Care, run by Unity Health Toronto at 1 site in Canada.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

The goal of this initial clinical trial is to gather information for building a future national trial in Canada that can continuously look at different ways of helping people made vulnerable get a primary care provider. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Access to Primary Care
What is being tested?
Primary care connector
Could I receive a placebo?
No, everyone receives an active treatment
How many people
200 participants
Where
1 siteCanada
Study dates
Mar 2026to Jul 2026
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Unattached adults (18+) made vulnerable who are seeking a primary care provider within the boundaries created by the Toronto Region Primary Care Workforce Planning Toolkit.

Who cannot join

  • Patients under 18 years old.
  • Patients above 18 years who have not been made vulnerable and are already registered and/or attached to a primary care organization within the boundaries created by the Toronto Region Primary Care Workforce Planning Toolkit.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Andrew D. Pinto, MD CCFP FRCPC MSc contact

416-864-6060 ext. 76148

andrew.pinto@utoronto.ca

Natricha A. Levy McFarlane, MPhil contact

416-864-6060 ext. 40218

natricha.levymcfarlane@unityhealth.to

Canada1 site
  • Unity Health Toronto

    Toronto, Ontario, M5B 1W8

    Andrew D. Pinto

    Andrew D. Pinto, MD CCFP FRCPC MSc

Other trials in Canada

About this study

Official title: Evaluating Novel Approaches That enGage And Support Vulnerable Patient Groups to Equitably Access Primary Care (ENGAGE): A Pilot Cluster Randomized Control Trial

The goal of this initial clinical trial is to gather information for building a future national trial in Canada that can continuously look at different ways of helping people made vulnerable get a primary care provider. The trial will take place in the Toronto region and will help researchers decide how to plan the future trial.

The main question that this trial is aiming to answer is:

Read more
  • For those made vulnerable who do not currently have a primary care provider, will assistance from a Primary Care Connector trained specifically with knowledge of the local health system, help to better connect those people to primary care providers compared to written information alone?

Researchers will compare giving participants the name of a provider that is accepting new patients in their area, to only giving participants existing information on how to find a provider, to see if giving the name of a provider accepting new patients works better to help people get connected to a provider.

Participants will:

  • Get the name of a primary care provider in their area who is accepting new patients or get existing information on how to find a primary care provider.
  • Call the provider to try and get an appointment or use the information given to find a provider.
  • Tell the study team if they have found a provider.
Read the detailed description

There is a serious crisis of people gaining access to primary care in Canada. It is estimated that 1 in 5 Canadians do not have a primary care provider. The challenge of access to primary care is exacerbated in populations that are made vulnerable such as newcomers, racialized individuals and low-income individuals.

In an effort to solve the access to primary care crisis, governments have announced billions in new funding, however, without planning and the engagement of patients made vulnerable by social and economic policies, these investments may actually widen inequities in access. Two key problems face policymakers: How to ensure investments reach and engage patients who are made vulnerable? How to adapt quickly, rather than implement a policy and wait years to decades before it is evaluated? Adaptive Platform Trials (APTs) are an ideal design to compare multiple approaches and to allow for new approaches to be added as they emerge.

APTs study multiple interventions in a single area in a perpetual manner, with new interventions allowed to enter or leave the platform over time based on a decision algorithm. APTs use a master protocol to establish standard operating procedures, including interim analyses to determine whether enrollment in interventions can be stopped early for statistical efficiencies (sequential designs). By using an APT design, researchers can respond swiftly to dynamic changes in policies and funding and continually refine strategies to ensure they remain effective and cost-effective.

The ENGAGE study will conduct a pilot cluster randomized control trial (cRCT) in two intervention and two comparison sub-regions in Toronto. Unattached adults (18+) made vulnerable who are seeking a primary care provider within the boundaries of the sub-regions of the study will be eligible to participate.

In the intervention sub-regions, posters bearing contact information for the study team will be displayed in public spaces including but not limited to bus stops and community notice boards. The study team will engage with primary care providers in the sub-regions to create a list of those accepting new patients, their general criteria for doing so and whether there are any exceptional circumstances under which they will accept new patients.

Persons made vulnerable who are unattached to primary care will contact the study team directly using the contact information from the posters. Primary care connectors will attempt to connect the unattached persons made vulnerable with a local primary care provider that can best serve them, based on the information gathered to create the list of practices accepting new patients. Because of this information, connectors may be able to more quickly direct those made vulnerable to primary care than they would be able to on their own. However, connectors will not guarantee that a connection to a local primary care provider will be made.

Posters will also be displayed in the the comparison sub-regions and persons made vulnerable who are seeking a primary care provider will contact the study team, similar to in the intervention sub-regions. Connectors will verbally inform participants of the existing resources for finding a primary care provider or services such as through Health Care Connect.

Connectors will follow-up with participants in both intervention and comparison sub-regions to to ascertain whether they were able to get access to a provider using the information that was shared with them. Access to a provider will be assessed as an appointment date or if the participant has been rostered with the provider.

Being tested
Primary care connector
Keywords
Primary care access, Adaptive platform trials, People made vulnerable, Primary care connector, Primary care attachment, Primary care engagement, Cluster randomized control trial

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Primary care connectorOther

    A primary care connector will give participants the name of a primary care provider in their area who is accepting new patients based on a list containing this information generated prior to the start of the trial.

Study groups in NCT07439627
Study groupRoleWhat they receive
Use of a primary care connectorOtherA primary care connector will try to connect participants to a primary care provider in their area.
Receives: Other: Primary care connector
Providing only information on finding a providerNo interventionParticipants will be provided with existing information on ways of finding a primary care provider.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Patient enrollment

    The number of patients made vulnerable enrolled in the primary care organizations across the participating sub-regions of the study is the primary outcome measure.

    Measured: From contact with a primary care connector to 3-4 weeks later.

Secondary outcomes (1)
  1. Appointment with a primary care provider

    An appointment to meet with a provider will also be an outcome measure. Appointments will be used along with enrollment as proxy measures to inform access and engagement of patients made vulnerable in primary care.

    Measured: From contact with a primary care connector to 3-4 weeks later.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted27 Feb 2026
  2. Study startMar 2026 (estimated)
  3. Primary completionJul 2026 (estimated)
  4. Study completionJul 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Health services research
Allocation
Non-randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
200 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07439627
Sponsor's protocol ID
24-186
Acronym
ENGAGE
Status last verified
Feb 2026
First submitted
23 Feb 2026
Last updated
3 Mar 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Primary care connector in people with Access to Primary Care, run by Unity Health Toronto at 1 site in Canada.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 3 Mar 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Canada. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Andrew D. Pinto, MD CCFP FRCPC MSc (416-864-6060 ext. 76148, andrew.pinto@utoronto.ca), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Patient enrollment (time frame: From contact with a primary care connector to 3-4 weeks later.). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Mar 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in